Abstract:Objective To study transcriptional characteristics of type Ⅲ procollagen gene in systemic scleroderma (SS)-derived fibroblast clones and their regulation by Radix Salviae miltiorrhizae(RSM).Methods Eight fibroblast clones with different collagen-producing capacity were previously obtained from patients with SS and normal human controls.Recombinant plasmids containing different deletions of the human alpha 1 chain of type 3 procollagen (COL3A1) gene promoter were constructed,and transiently transfected into the fibroblast clones.Dual-luciferase reporter assay system was used to evaluate the activities of these recombinants in the fibroblast clones and to select a proximal transcriptional regulatory sequence.Then,the fibroblast clones were transfected with the plasmid containing the selected regulatory sequence (phCOLH30.1) followed by the treatment with RSM injection (1 g/L) and active monomers of RSM,including salvianolic acid B (5 mg/L),tanshinone Ⅱ A (5 mg/L),danshensu (20 mg/L) and protocatechuic aldehyde (5 mg/L),for 48 hours.The transfected fibroblast clones receiving no drug treatment served as the water-soluble control,and those treated with only dimethyl sulfoxide as the lipid-soluble control.Subsequently,the fibroblasts were lysed and subjected to the quantification of cellular proteins and determination of luciferase activity.The activity of recombinant promoters was compared by t test for the selection of proximal transcriptional regulatory sequence,and the activity of phCOLH30.1 by two-way analysis of variance in the RSM-interfering test (if there was interaction,one-way analysis of variance was conducted; and if there was no interaction,the main effect was tested after the removal of interaction item).Results Of the 6 recombinants,the recombinant containing COL3A1 proximal promoter from -96 bp to +16 bp (phCOLH30.1) showed the highest transcriptional activity in nearly all of the fibroblast clones,and the activity was positively correlated with the collagen-producing capacity of fibroblast clones.Compared with the water-soluble control,RSM injection significantly downregulated the activity of phCOLH30.1 in fibroblast clones with high and low collagen-producing capacity from patients with SS (2.261 ± 0.619 vs.3.879 ± 0.309,1.462 ± 0.291 vs.2.150 ± 0.262,both P ＜ 0.01) and normal human controls (1.681 ± 0.263 vs.3.039 ± 0.271,1.121 ± 0.361 vs.2.223 ± 0.247,both P ＜ 0.01),salvianolic acid B decreased the phCOLH30.1 activity in SS-derived high collagen-producing fibroblast clones (2.309 ± 0.524,P ＜ 0.01 ) and in the normal control fibroblast clones with high and low collagen-producing capacity (2.126 ± 0.320 and 1.976 ± 0.362,both P ＜ 0.05).Tanshinone Ⅱ A only downregulated the phCOLH30.1 activity in SS-derived high collagen-producing fibroblast clones compared with the lipid-soluble control (2.975 ± 0.666 vs 5.379 ± 0.238,P ＜ 0.01 ).Neither danshensu nor protocatechuic aldehyde showed inhibitory effects on phCOLH30.1 activity in SS-derived or normal control fibroblast clones.Conclusions The type Ⅲ procollagen gene is activated at the transcriptional level in high collagen-producing fibroblast clones from patients with SS,and the activation could be suppressed by RSM injection,salvianolic acid B and tanshinone Ⅱ A.

The Heterogeneity of Clonal SSc Skin Fibroblasts in Collagen Metabolism

Effects of Peripheral Blood Mononuclear Cells on the Collagen Metabolism of Cloned Systemic Scleroderma Skin Fibroblasts

Transcriptional Characteristics of Type Ⅰ Procollagen Gene of Fibroblast Clones from Patients with Systemic Sclerosis

[Mrna Expression of Procollagen and SMADs in Lesional Skin of Progressive Systemic Sclerosis].

Growth Heterogeneity of Skin Fibroblast Clones from Patients with Systemic Sclerolerma

Systemic Sclerosis Dermal Fibroblasts Induce Cutaneous Fibrosis Through Lysyl Oxidase–like 4: New Evidence from Three‐Dimensional Skin‐like Tissues

Transcriptional Regulation of TGF-β1、CTGF and IFN-γ on Type Ⅰ and Ⅲ Procollagen Gene in Scleroderma Fibroblast Clones with Different Collagen-Producing Capacity

[Expression and distribution of type I, III and V collagens in skin lesions from patients with systemic sclerosis]

Elevated Alpha 1(I) to Alpha 2(I) Collagen Ratio in Dermal Fibroblasts Possibly Contributes to Fibrosis in Systemic Sclerosis

Transcriptional Characteristics of Type Ⅲ Procollagen Gene in Systemic Scleroderma-Derived Fibroblast Clones and Their Regulation by Radix Salviae Miltiorrhizae

Expression of activin receptor-like kinases 1 in dermal fibroblasts from patients with systemic scleroderma and its roles

Classification Analysis of the Transcriptosome of Nonlesional Cultured Dermal Fibroblasts from Systemic Sclerosis Patients with Early Disease.

Transcriptional Regulation of Type Ⅰ Procollagen Gene in Scleroderma-Derived High Collagen-Producing Fibroblast Clones by Radix Salviae Miltiorrhizae

Role of endothelin-1 in the skin fibrosis of systemic sclerosis

Imaging mass cytometry-based characterisation of fibroblast subsets and their cellular niches in systemic sclerosis

Distinct T cell chromatin landscapes in scleroderma subtypes

Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease

Alternative splicing and intron retention: Their profiles and roles in cutaneous fibrosis of systemic sclerosis

Modulation by 17,20S(OH)2pD of Fibrosis-Related Mediators in Dermal Fibroblast Lines from Healthy Donors and from Patients with Systemic Sclerosis

Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha

Increased Frequency of Th17 Cells in Systemic Sclerosis is Related to Disease Activity and Collagen Overproduction.